Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanand Sarkar

Showing results (81-90 of 289) with videos related to

Pageof 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2018
Reply to Yoshida: Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cellsSarmistha Talukdar, Swadesh K Das, Luni Emdad, et al.
Cancer Research|October 20, 2004
Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammationDevanand Sarkar, Irina V Lebedeva, Luni Emdad, et al.
Cancer Research|February 3, 2006
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasisLuni Emdad, Devanand Sarkar, Zao-zhong Su, et al.
Cancer Research|March 5, 2008
Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1Devanand Sarkar, Eun Sook Park, Luni Emdad, et al.
Oncoimmunology|May 4, 2016
Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimeticSiddik Sarkar, Anjan Pradhan, Swadesh K Das, et al.
FEBS Letters|June 25, 2016
Tetraspanin 8 mediates AEG-1-induced invasion and metastasis in hepatocellular carcinoma cellsMaaged A Akiel, Prasanna K Santhekadur, Rachel G Mendoza, et al.
Gene|June 2, 2005
Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1Dong-Chul Kang, Zao-Zhong Su, Devanand Sarkar, et al.
Oncotarget|November 19, 2016
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancerMitchell E Menezes, Xue-Ning Shen, Swadesh K Das, et al.
Expert Opinion on Investigational Drugs|February 8, 2014
Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trialsShilpa Bhatia, Luni Emdad, Swadesh K Das, et al.
Advances in Cancer Research|July 23, 2013
Therapeutic cancer vaccines: past, present, and futureChunqing Guo, Masoud H Manjili, John R Subjeck, et al.
Pageof 29

Showing results (81-90 of 289) with videos related to

Sort By:
Pageof 29
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2018
Reply to Yoshida: Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cellsSarmistha Talukdar, Swadesh K Das, Luni Emdad, et al.
Cancer Research|October 20, 2004
Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammationDevanand Sarkar, Irina V Lebedeva, Luni Emdad, et al.
Cancer Research|February 3, 2006
Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasisLuni Emdad, Devanand Sarkar, Zao-zhong Su, et al.
Cancer Research|March 5, 2008
Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1Devanand Sarkar, Eun Sook Park, Luni Emdad, et al.
Oncoimmunology|May 4, 2016
Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimeticSiddik Sarkar, Anjan Pradhan, Swadesh K Das, et al.
FEBS Letters|June 25, 2016
Tetraspanin 8 mediates AEG-1-induced invasion and metastasis in hepatocellular carcinoma cellsMaaged A Akiel, Prasanna K Santhekadur, Rachel G Mendoza, et al.
Gene|June 2, 2005
Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1Dong-Chul Kang, Zao-Zhong Su, Devanand Sarkar, et al.
Oncotarget|November 19, 2016
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancerMitchell E Menezes, Xue-Ning Shen, Swadesh K Das, et al.
Expert Opinion on Investigational Drugs|February 8, 2014
Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trialsShilpa Bhatia, Luni Emdad, Swadesh K Das, et al.
Advances in Cancer Research|July 23, 2013
Therapeutic cancer vaccines: past, present, and futureChunqing Guo, Masoud H Manjili, John R Subjeck, et al.
Pageof 29